cryptotanshinone has been researched along with Glioma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, M; Li, C; Li, D; Liu, P; Lu, L; Shen, X; Zhang, S; Zhou, C | 1 |
Li, C; Li, D; Lu, L; Peng, J; Shao, W; Shen, X; Wang, Y; You, Y; Zhang, X; Zhou, C | 1 |
2 other study(ies) available for cryptotanshinone and Glioma
Article | Year |
---|---|
Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Female; Glioma; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Phenanthrenes; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Cryptotanshinone inhibits human glioma cell proliferation by suppressing STAT3 signaling.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; G1 Phase; Glioma; Humans; Mutant Proteins; Phenanthrenes; Phosphorylation; Phosphotyrosine; Rats; RNA, Small Interfering; S Phase; Signal Transduction; STAT3 Transcription Factor | 2013 |